MedPath

Patient Reported Outcome Instruments in Sarcoidosis

Conditions
Sarcoidosis
Registration Number
NCT04342403
Lead Sponsor
University of Cincinnati
Brief Summary

Evaluate change of quality of life of sarcoiodosis patients over a six months using various quality of life instruments including a monthly smart phone app.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Diagnosis of sarcoidosis by established criteria.
  • Patient has completed pulmonary function tests (spirometry) as per standard of care at the enrollment visit.
  • Ability to understand and read English at least at a 7th grade level.
  • Have access to a computer, iPad, smart phone, or another electronic device that will support the on-line sarcoidosis assessment platform.
  • The subject is willing to wear a daily activity and sleep tracker wristband (Fitbit ™ wristband) for 6 months.
Exclusion Criteria

• Life expectancy of < 1 year.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
KSQ6 months

Change in KSQ

Secondary Outcome Measures
NameTimeMethod
Forced Vital Capacity (FVC)6 months

Change in FVC percent predicted

Visual Analog Scale (VAS)6 Months

Change in VAS

SAT6 Months

Change in SAT

Trial Locations

Locations (3)

Albany Medical Center

🇺🇸

Albany, New York, United States

University of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Albany Medical Center
🇺🇸Albany, New York, United States
Marc Judson, MD
Contact
518-262-5196
JudsonM@amc.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.